Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Read more in #EHJ
European Society of Cardiology European Society of Cardiology Journals #CardioTwitter

academic.oup.com/eurheartj/adva…

This month we are returning with another heart muscle talks session! We are looking forward to Roddy Walsh 🇪🇺 🇺🇦 presenting on one of the most interesting topics in the field!

register here 👉 ucl.zoom.us/webinar/regist…

Advocating the need for more clinical and basic #research to combat #CardiovascularDisease at the #VoteHealth2024 exhibit at the European Parlement

European Society of Cardiology European Society of Cardiology Advocacy European Alliance for Cardiovascular Health (EACH) #cardiotwitter #CardiovascularResearch #CVD ESC President

Mavacamten, a myosin inhibitor, is the first disease-specific treatment for obstructive hypertrophic cardiomyopathy. Read more in #EHJ .
doi.org/10.1093/eurhea…
#hypertrophic #cardiomyopathy #myosin #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

Don’t miss this great #ESC #Escgenomics Focus on cardiomyopathies
👉 escardio.org/Education/ESC-…

🙏👏Elena Arbelo Juan Pablo Kaski Sara Moscatelli Ronen Beeri & Gabrielle Norrish

Upcoming European Society of Cardiology webinars discussing 🆕 #cardiomyopathies guidelines with members of the Task Force! 🆓 registration for #ESC professional members! Register now esc365.escardio.org/event/1062?utm…
Juan Pablo Kaski Pablo Garcia-Pavia Alex Protonotarios Ruxandra Jurcut Elena Arbelo Silvia Castelletti Massimo Imazio

!! #ESC Cardio Genomics 2023: registration & call for abstracts now open!!
#ESC genomics #MedTwitter

👉Join us in Naples, 21 – 22 October 2023.
☝️Open to every HCP in link with genomic medicine, and researchers

esc365.escardio.org/event/1089

New #ESCGuidelines on #cardiomyopathy discussed by the taskforce at #ESCCongress2023
Glad 😀 to see patients and #geneticcounselors having an established role and that 🧬 testing needs counseling!
👏👏👏to the Taskforce & Reviewers!

Great summary of ATTRibute-CM results. Exciting (and also complex) times ahead!!

Breaking news #ESCCongress - ATTRibute-CM TRIAL: Acoramidis improves outcomes in patients with ATTR-CM compared with placebo
Victoria Delgado Dr Roxana Mehran
MIЯVΛƬ #IC David Duncker
C. Michael Gibson MD chief
Henry Han Jozine ter Maaten
Mewton Nathan Maggie Simpson
Amina

Very exciting data at #esc #session on genes and gene editing in heart failure! A quick but very efficient look into the (close) future! 🙏 #esc genomics Prof Chris Semsarian AM Andreas Zeiher Silvia Priori @laurazelarayan2 Mauro Giacca

#ESC2023 Guidelines for the management of #cardiomyopathies

In this guideline, is proposed the new term non-dilated left ventricular cardiomyopathy (NDLVC)
👇 more details in the thread

Work for the weekend

academic.oup.com/eurheartj/arti…

First #cardiooncology meeting between Institut Jules Bordet Instituut and @Erasme Hospital @HUB Ruben Casado Arroyo Antoine Bondue casalino giulia @AhmadAwada @SergeMottte @AudreyVervacke International Cardio-Oncology Society European Society of Cardiology OncoAlert

Evidence-Based Assessment of Congenital Heart Disease Genes to Enable Returning Results in a Genomic Study

AHA Science #AHAjournals #CardioTwitter

Video abstract by Vibhu Parcha

enjoying a very nice dinner with the Belgian WG on #ACHD - making plans - always inspiring with ⁦Alexander Vd Bruaene⁩ ⁦werner budts⁩ ⁦Antoine Bondue⁩ ⁦Sophie Pierard⁩ ⁦Laura Anghel⁩

Vers un plan national « Maladies cardiovasculaires » en Belgique ? bit.ly/3Opyw4J LigueCardioLiga Antoine Bondue Nathalie Muylle Daniel Bacquelaine SPF Santé publique Jean Creplet @j_detoeuf INAMI

Cardiomyopathies Matter.